Search company, investor...
eZono company logo


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$10M | 10 yrs ago

About eZono

eZono develops and markets tablet style ultrasound systems for emerging markets like regional anaesthesia and emergency care. The company's eZono 3000 is a portable ultrasound system designed for the needs of anaesthetists, emergency care and a rising number of new applications. It accelerates the learning curve with its CUE CARDS, a multi-media learning and workflow tool for new applications.

Headquarters Location

Spitzweidenweg 30

Jena, D-07743,


+49(0)3641 876 1740

Missing: eZono's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: eZono's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing eZono

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

eZono is included in 3 Expert Collections, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)


Health Monitoring & Diagnostics

65 items

Companies developing technology to facilitate point-of-care (POC) diagnostic imaging. Excludes intraoperative imaging. Companies tagged as #PointOfCareImaging


Health IT

363 items

eZono Patents

eZono has filed 1 patent.

The 3 most popular patent topics include:

  • Medical equipment
  • Medical imaging
  • Medical ultrasonography
patents chart

Application Date

Grant Date


Related Topics




Medical equipment, Image processing, Surgical instruments, Medical ultrasonography, Medical imaging


Application Date


Grant Date



Related Topics

Medical equipment, Image processing, Surgical instruments, Medical ultrasonography, Medical imaging



Latest eZono News

CME Medical to distribute eZono 4000 for use in multiple clinical settings

May 15, 2015

Published on May 15, 2015 at 6:59 AM· No Comments CME Medical, the market leader in the specialist infusion pump field, is delighted to announce its partnership with eZono, AG, a company that focuses on ultrasound for procedural guidance, to distribute its flagship product the eZono® 4000. The eZono® 4000 represents a new era of imaging, needle guidance and education. Using revolutionary technology to provide advanced functionality for procedural guidance, with the simplicity and reliability requested and required by clinicians. The eZono® 4000 can be used for a wide range of applications and procedures in multiple clinical settings. CME Medical’s dedication to patient well-being, alongside its reputation for providing education, support and training across the market makes the organisation an ideal partner for eZono. The Blackpool based company champions innovative healthcare solutions and sees this as a natural extension to its existing portfolio in IV therapy. The eZGuide FreePlane Navigation within the eZono 4000® is a unique and revolutionary needle guidance system technology that enables clinicians to easily target desired anatomy in or out of plane without any additional hardware or proprietary needles. Thus, reducing costs and improving efficiency and accuracy. CME Medical is dedicated to educating existing and potential customers on the unique benefits of the eZono® 4000 including: eZGuide FreePlane Navigation with Adaptive Needle Recognition: Proprietary needle guidance technology lets you know exactly where you are in relation to your target. Precision: eZGuide’s technology allows precise needle placement from any plane. Time Savings: eZGuide’s revolutionary needle guidance technology improves efficiency. Customer Education: Cue Card onboard Education offers detailed step by step instructions, along with 3D anatomical illustrations, allowing clinicians to practice as they scan. Clinical Outcomes: Improved accuracy means decreased complications and better outcomes. Cost Savings: eZGuideTM requires no additional expensive hardware, proprietary needles or special gauges Increase patient comfort: Reduction of anxiety and pain. Reduces multiple puncture attempts, thus, potentially reducing infection rates. Reduced risk of infection from needle re-entry. John Carrington, Managing Director of CME Medical comments: The eZono® 4000 offers a unique new approach to the patient pathway, and we’re pleased to welcome it into the CME Medical product portfolio to complement our existing range. This gold standard in care benefits both practitioner and patient, creating the safest and most comfortable environment for these procedures. As a leader in the portable infusion sector our existing customers already have exposure to ultrasound products, providing us with a great platform to start educating them about the benefits of the eZono® 4000. Tracey Byard, General Manager at eZono AG comments: With CME Medical’s reputation for providing expert training and advice to ensure their products are used safely and effectively, we know we are partnering with a company that shares the same values. Our training with the CME Medical team has already begun and we will continue to work together to increase existing product knowledge. We are committed to working alongside the team to create a network of support, bringing together our knowledge of the ultrasound field with CME Medical’s extensive experience in the infusion sector. Source:

eZono Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

eZono Rank

eZono Frequently Asked Questions (FAQ)

  • When was eZono founded?

    eZono was founded in 2004.

  • Where is eZono's headquarters?

    eZono's headquarters is located at Spitzweidenweg 30, Jena.

  • What is eZono's latest funding round?

    eZono's latest funding round is Unattributed VC.

  • How much did eZono raise?

    eZono raised a total of $10M.

  • Who are the investors of eZono?

    Investors of eZono include MVM Partners, bm-t beteiligungsmanagement thuringen and KfW.

  • Who are eZono's competitors?

    Competitors of eZono include Exo and 5 more.

Compare eZono to Competitors


M-SCAN develops portable mobile ultrasound devices that are laptop, tablet and mobile phone compatible.

Clarius Mobile Health

Clarius’ mission is to make accurate, easy-to-use and affordable ultrasound tools available to all medical professionals. Its handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high resolution ultrasound images traditionally only available with bulkier, high end systems.

BURL Concepts Logo
BURL Concepts

BURL Concepts is developing a portable, battery-powered ultrasound device designed for the non-invasive, transcranial diagnosis of strokes 'In The Field'. Using disposable ultrasound transducers it works in combination with ultrasound microbubbles. Acoustic Response Analysis (ARA) has been developed as a technology to adapt automatically the acoustic output power to the individual skull 'finger print' of a patient. Based on acoustic pattern recognition ARA allows to differentiate between underlying hemorrhagic or ischemic events as a cause for the stroke. The BURL Device carries wireless technology for real-time data transfer to a dedicated location.

Echometrix Logo

Echometrix is a developer of proprietary ultrasound technology. The company is focused on creating rapid growth in the markets for portable ultrasound, musculoskeletal imaging, and orthopedics.


Exo is a health information and devices company. Exo believes everyone around the world should have access to high-quality, affordable, and easy-to-use medical imaging. Its mission is to modernize medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. Exo’s goal is to enable healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes. The company was founded in 2016 and is based in Redwood City, California.

Signostics Logo

Signostics is a developer of handheld ultrasound devices and bladder scanners. The company's patented SignosRT Bladder Scanner is a device that utilizes ultrasound technology to automate detection of the bladder and calculation of its volume.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.